Skip to main content
Clinical Trials/NCT03135431
NCT03135431
Completed
Not Applicable

Opportunistic Salpingectomy at the Time of Cesarean Delivery: A Randomized Controlled Trial of the Safety of Salpingectomy vs Tubal Ligation

Mayo Clinic1 site in 1 country40 target enrollmentMay 17, 2017
ConditionsContraception

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Contraception
Sponsor
Mayo Clinic
Enrollment
40
Locations
1
Primary Endpoint
Mean Difference Between Pre and Postoperative Hemoglobin (g/dl)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The purpose of this study is to compare the safety of performing a bilateral tubal ligation vs. bilateral salpingectomy, two procedures performed for permanent sterilization, at the time of cesarean delivery. The investigators want to determine if performing bilateral salpingectomy at the time of cesarean delivery poses any greater risk for blood loss, as compared to a bilateral tubal ligation.

Detailed Description

A non-inferiority, two-arm randomized controlled trial to evaluate the safety and feasibility of prophylactic salpingectomy at the time of a cesarean delivery will be conducted as an initiative to avoid a missed opportunity in the primary prevention of ovarian cancer. Once enrolled and consented, women will be randomized using a stratified block randomization algorithm according to number of prior cesarean deliveries and BMI to either salpingectomy or bilateral tubal ligation. The data collection will include preoperative CBC, time of procedure, postoperative CBC at 24 hours, standard patient demographics, procedural complications, estimated blood loss, return to the OR, length of stay, pain scores, and postoperative complications, including readmission within 6 weeks.

Registry
clinicaltrials.gov
Start Date
May 17, 2017
End Date
July 30, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Vanessa Torbenson

Consultant Obstetrics and Gynecology

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Pregnant women
  • 21 years of age or older
  • Desire permanent sterilization
  • Scheduled for a Cesarean delivery

Exclusion Criteria

  • Body Mass Index \> 50
  • Emergent, 'alpha' Cesarean delivery
  • Single ovary/fallopian tube complex

Outcomes

Primary Outcomes

Mean Difference Between Pre and Postoperative Hemoglobin (g/dl)

Time Frame: At least 24 but not greater than 48 hours after surgery

Identify the mean difference in pre and postoperative hemoglobin for patients undergoing salpingectomy for sterilization vs. patients undergoing standard bilateral tubal ligation via mid-segment resection of the fallopian tube at the time of cesarean delivery.

Secondary Outcomes

  • Operative Time(Day of surgery)
  • Estimated Blood Loss(Day of surgery)

Study Sites (1)

Loading locations...

Similar Trials